Hosted on MSN3h
Drugs approved for other diseases may unlock a faster path to Alzheimer’s treatment, UNLV researcher saysDoctor Jeffrey Cummings is world-renowned in the field of Alzheimer's research and he leads UNLV's Center for Transformative ...
The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in ...
The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...
12h
A clinical research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), and international genetic researchers led a global research study using multi-omics analysis and ...
Neurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback